Mira Pharmaceuticals Inc (NASDAQ:MIRA) has a beta value of 3.14 and has seen 3.19 million shares traded in the last trading session. The company, currently valued at $28.08M, closed the last trade at $1.90 per share which meant it lost -$0.29 on the day or -13.24% during that session. The MIRA stock price is -236.84% off its 52-week high price of $6.40 and 73.16% above the 52-week low of $0.51. If we look at the company’s 10-day average daily trading volume, we find that it stood at 6.24 million shares traded. The 3-month trading volume is 2.12 million shares.
Mira Pharmaceuticals Inc (NASDAQ:MIRA) trade information
Sporting -13.24% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on recent trading when the MIRA stock price touched $1.90 or saw a rise of 25.78%. Year-to-date, Mira Pharmaceuticals Inc shares have moved 80.95%, while the 5-day performance has seen it change 47.29%. Over the past 30 days, the shares of Mira Pharmaceuticals Inc (NASDAQ:MIRA) have changed 62.39%. Short interest in the company has seen 0.34 million shares shorted with days to cover at 0.7.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Mira Pharmaceuticals Inc (MIRA) estimates and forecasts
Figures show that Mira Pharmaceuticals Inc shares have underperformed across the wider relevant industry. The company’s shares have gained 159.21% over the past 6 months, with this year growth rate of 6.25%, compared to 17.50% for the industry.
MIRA Dividends
Mira Pharmaceuticals Inc is expected to release its next earnings report in December this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Mira Pharmaceuticals Inc (NASDAQ:MIRA)’s Major holders
Insiders own 27.21% of the company shares, while shares held by institutions stand at 5.03% with a share float percentage of 6.91%. Investors are also buoyed by the number of investors in a company, with Mira Pharmaceuticals Inc having a total of 14.0 institutions that hold shares in the company.
